Chee Conley has filed 11 insider transactions across 1 company since March 2024.
Most recent transaction: a sale of 134797 shares of Syros Pharmaceuticals, Inc. ($SYRS) on November 18, 2024.
Activity breakdown: 2 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 18, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Chee Conley | President & CEO | S | Common Stock | 134797 | $0.20 | 0.0000 | 39,335,772 | 100.00% | 0.34% |
| Oct. 31, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Chee Conley | President & CEO | M | Common Stock | 17000 | $0.00 | 139,504.0000 | 39,335,772 | 13.88% | 0.04% |
| Oct. 31, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Chee Conley | President & CEO | F | Common Stock | 8707 | $2.09 | 130,797.0000 | 39,335,772 | 6.24% | 0.02% |
| Oct. 31, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Chee Conley | President & CEO | M | Restricted Stock Units | 17000 | $0.00 | 0.0000 | 39,335,772 | 100.00% | 0.04% |
| Sept. 10, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Chee Conley | President & CEO | P | Common Stock | 50000 | $1.51 | 72,504.0000 | 28,325,779 | 222.18% | 0.18% |
| Sept. 11, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Chee Conley | President & CEO | P | Common Stock | 50000 | $1.71 | 122,504.0000 | 28,325,779 | 68.96% | 0.18% |
| March 31, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Chee Conley | President & CEO | M | Common Stock | 2000 | $0.00 | 14,338.0000 | 28,325,779 | 16.21% | 0.01% |
| March 31, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Chee Conley | President & CEO | M | Common Stock | 11666 | $0.00 | 26,004.0000 | 28,325,779 | 81.36% | 0.04% |
| April 1, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Chee Conley | President & CEO | F | Common Stock | 3500 | $5.12 | 22,504.0000 | 28,325,779 | 13.46% | 0.01% |
| March 31, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Chee Conley | President & CEO | M | Restricted Stock Units | 2000 | $0.00 | 4,000.0000 | 28,325,779 | 33.33% | 0.01% |
| March 31, 2024 | Syros Pharmaceuticals, Inc. | $SYRS | Chee Conley | President & CEO | M | Restricted Stock Units | 11666 | $0.00 | 23,334.0000 | 28,325,779 | 33.33% | 0.04% |